Chemical Property of Ebrotidine
Chemical Property:
- Vapor Pressure:6.2E-18mmHg at 25°C
- Melting Point:142.5-146℃
- Refractive Index:1.739
- Boiling Point:672.3 °C at 760 mmHg
- PKA:5.25±0.40(Predicted)
- Flash Point:360.4 °C
- PSA：195.24000
- Density:1.73 g/cm3
- LogP:4.79570
- Storage Temp.:Amber Vial, -20°C Freezer, Under inert atmosphere
- Solubility.:DMSO (Slightly), Methanol (Slightly)
- XLogP3:1.5
- Hydrogen Bond Donor Count:3
- Hydrogen Bond Acceptor Count:7
- Rotatable Bond Count:9
- Exact Mass:475.97585
- Heavy Atom Count:26
- Complexity:586
- Purity/Quality:
-
99% *data from raw suppliers
Ebrotidine *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Canonical SMILES:C1=CC(=CC=C1S(=O)(=O)NC=NCCSCC2=CSC(=N2)N=C(N)N)Br
-
Description
Ebrocit was launched in Spain as a gastroprotective agent. It was prepared
from 4-bromobenzenesulfonamide in two steps. Ebrocit's activity arises from its ability
to antagonize histamine H2-receptors (the first of a new generation) showing 1.5-2.5
times higher affinity than Ranitidine and 2-fold greater affinity than cimetidine which
correlates to an antisecretory potency of 1 times and 4-10 times respectively. Cytoand
gastroprotection arises from increased gastric mucus production, enhanced
physiochemical properties (decreased permeability of H+), and an increase in mucin
glycosylation and sulfation. It acts on gastric mucosal EGF and PDGF receptor
expression. Nitric oxide was also found to be involved. Ebrocit caused enhanced
mucosal blood flow with anti H.pylori activity. It has diminished P450 binding which
eliminates the possibility of mutagenic nitrosoamine formation.
-
Uses
Ebrotidine is a H2 receptor antagonist that has shown gastroprotective properties against gastric mucosal damange.
